Marron d'Inde Jambes légères BIO
Food supplement declared in France, declaration No 2023-5-1036
Marron d'Inde Jambes légères BIO (Laboratoires Vitarmonyl) is a food supplement declared in France. Status: withdrawal from the market announced for 21 August 2028. Main ingredients: Aesculus hippocastanum 250 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- Laboratoires Vitarmonyl
- Food business operator placing the product on the market
- Laboratoires VITARMONYL
- Status
- Withdrawal from the market announced for 21 August 2028
- Form
- Capsule
- Daily dose
- 1 gélule
- Directions for use
- à avaler avec un verre d'eau
- Not recommended (according to the manufacturer)
- Taking anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Blood and lymphatic circulation
Declaration 194653, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Aesculus hippocastanum L. | Graine | Extrait sec aqueux | 250 mg |
Other ingredients
Gélule végétale, poudre de cacao
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Regulatory points
- Information
Withdrawal from the market announced for 21 August 2028, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Aesculus hippocastanum L.
Read the warning, when it applies and the studies cited
Horse Chestnut - Aesculus Hippocastanum
Route of administration: Oral (Bradley 2006; ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Laboratoires Vitarmonyl
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Marron d'Inde Jambes légères BIO (Laboratoires Vitarmonyl): composition and regulation”, https://compoatlas.com/en/supplements/products/194653-marron-d-inde-jambes-legeres-bio, updated 15 November 2026.